Form D · Pharmaceuticals

Orca Pharmaceuticals, LLC

Cleveland, OH · CIK 0001575447

Offering snapshot reported Aug 14, 2014 · SEC filing

Reported sold
$2.61M
Offering amount: $5M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 15, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.31M$2.61MAug 29, 2013: $800,000.00Aug 29, 2013Mar 17, 2014: $1,200,000.00Mar 17, 2014Aug 14, 2014: $2,610,000.00Aug 14, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,200,000 → $2,610,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 14, 2014Amendment$2,610,000$1,410,000vs Mar 17, 20148SEC filing
Mar 17, 2014Amendment$1,200,000$400,000vs Aug 29, 20138SEC filing
Aug 29, 2013Initial$800,000No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-202057

Source: Form D, filed Aug 14, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas Facklam Director
Al Hawkins Promoter
Michael Hunter Director
Roy Pettipher Director
Baiju Shah Director, Promoter
Theodore Torphy Director
David U'prichard Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
20600 Chagrin Blvd. Suite 210
Cleveland, OH, 44122